salon:Turing Pharmaceutical founder and CEO Martin Shkreli defended his 5,455 percent hike in the pr
salon:Turing Pharmaceutical founder and CEO Martin Shkreli defended his 5,455 percent hike in the price of a drug used by pregnant women and immunocompromised patients, saying that “Daraprim is still under-priced relative to its peers.”Despite the fact that “it costs very little to make Daraprim” and that the company was still profiting off sales of it at $13.50, Shkreli said that his company was “practically giving it away” before raising the price per pill to $750.“This drug was making $5 million in revenue,” he said, “and I don’t think you can find a drug company on the planet that can make money on $5 million of revenue.”“To save your life — was only $1,000″ -- source link